baber/WOPTO huggingface dataset:
Patent EP-1239696-A2 (EP)
Inventor: SPARKS ADRIAN
IPC: G02B6/35
Filed: 2001-12-20
Abstract: An optical switch comprising two segments at least partially separated by a surface
that is partially reflective and partially transmissive to the optical signals being switched,
each segment having at least one optical input and at least one optical output, the
segments being arranged such that an optical signal can be switched from said input to
said output by reflection from said surface, with the optical signal that is generated by
transmission through said surface being directed to an output of the other segment.
Patent EP-1209890-A2 (EP)
Inventor: MARTZLOFF FRANCOIS
IPC: H04L45/28
Filed: 2001-11-20
Abstract: Cette invention concerne une installation de surveillance d'un site à surveiller (2) à partir d'un site de surveillance (18), raccordés entre eux par des moyens (12) de transmission d'informations, le site à surveiller (2) comportant des premiers moyens (8) d'émission/réception d'informations de surveillance connectés aux moyens (12) de transmission et le site de surveillance (18) comportant des seconds moyens (10) d'émission/réception d'informations raccordés aux moyens (12) de transmission. Les moyens (12) de transmission comportent un canal principal (14), un canal de secours (16), et les moyens (8, 10) d'émission/réception des sites (2, 18) comprennent des moyens de surveillance de l'intégrité de ces canaux pour basculer la transmission des informations du canal principal (14) sur le canal de secours (16) en cas de dysfonctionnement du canal principal et des moyens d'échange d'informations codées d'identification des sites. <IMAGE>
Patent EP-1168771-A2 (EP)
Inventor: DUBLER ANDREAS M
IPC: G06F19/00
Filed: 2001-05-18
Abstract: A method of exchanging information between one of a plurality of doctors and one of a plurality of hospitals is disclosed. According to this method, on an operating platform, a data set containing hospital related information including information about hospital occupancy is maintained. On a client system of said one doctor, information relating to at least some of the plurality of hospitals including information from said data set is displayed. The doctor may then send a request signal to the operating platform, thereby generating a reservation order created by said operating platform. This reservation order is then sent to one of said plurality of hospitals, the hospital being specified by information contained in the request signal. Finally, depending on the successful transmittal of said reservation order, said data set containing hospital occupancy information is modified.
Patent EP-1276475-A2 (EP)
Title: Formulations topiques a base d'anesthesique et d'opioide, et utilisations associees
Inventor: PASTERNAK GAVRIL
IPC: A61K31/4745
Filed: 2001-04-27
Abstract: Il est connu que bien des compositions chimiques et pharmaceutiques produisent des effets anti-nociceptifs qui aident à soulager la douleur et l'inflammation. Les opioïdes et les anesthésiques locaux jouent tous deux un rôle important dans le soulagement de la douleur périphérique. L'administration topique, sur la périphérie, de médicaments sédatifs de la douleur, constitue un avantage important par rapport à l'administration systémique ou locale et non topique. L'invention concerne des compositions pharmaceutiques topiques, formulées à l'aide d'au moins un anesthésique local et d'au moins un analgésique opioïde, dans un véhicule topique. L'invention concerne également des procédés consistant à soulager la douleur chez un sujet par administration topique de cette composition pharmaceutique, selon une dose et pendant une durée suffisantes pour potentialiser de manière synergique une réponse anti-nociceptive. La potentialisation synergique de l'analgésie obtenue par l'administration topique d'une composition pharmaceutique à base d'un anesthésique local et d'un opioïde, constitue une nouvelle et meilleure approche de la gestion de la douleur périphérique.
Patent EP-1276730-A2 (EP)
Inventor: DRUZGALA PASCAL
IPC: C07D261/12
Filed: 2001-04-24
Abstract: The subject invention provides pharmaceutical compounds useful in the treatment of Type II diabetes. These compounds are advantageous because they are readily metabolized by the metabolic drug detoxification systems. Particularly, thiazolidinedione analogs that have been designed to include esters within the structure of the compounds are provided. This invention is also drawn to methods of treating disorders, such as diabetes, comprising the administration of therapeutically effective compositions comprising compounds that have been designed to be metabolized by serum or intracellular hydrolases and esterases. Pharmaceutical compositions of the ester-containing thiazolidinedione analogs are also taught.
Patent EP-1280495-A2 (EP)
Inventor: ABBOTT THOMAS P
IPC: C07C53/00
Filed: 2001-04-23
Abstract: 1-(3-methoxybenzyl)-3-substituted thiourea antioxidant compounds and improved lipids compositions which are supplemented with amounts of such antioxidant compounds effective for augmenting oxidative stability of the base lipid are provided. Also provided are methods for enhancing the oxidative stability of a lipid comprising supplementing a base lipid in  need of enhanced oxidative stability with at least one 1-(3-methoxybenzyl)-3-substituted thiourea compound of the present invention.
Patent EP-1368489-A2 (EP)
Inventor: CHEN CAIFU
IPC: C12Q1/68
Filed: 2001-06-06
Abstract: L'invention concerne un protocole de formation de cycle thermique asynchrone pour amplification d'acide nucléique, utilisant deux amorces à des températures de fusion thermique différentes d'environ 10 à 30 °C. Une fois que l'amorce à fusion la plus élevée a été annelée et qu'une extension a été régulée par la polymérase, la séquence cible simple brin non copiée peut être hybridée et détectée au moyen d'une sonde. Des sondes d'ADN peuvent être clivées par l'activité de l'exonucléase d'une polymérase. La sonde peut être un analogue non clivé tel que PNA. Lorsqu'une sonde est marquée au moyen d'un colorant rapporteur et qu'un agent d'extinction est sélectionné de façon à effectuer un transfert d'énergie, par exemple FRET, la fluorescence provenant dudit colorant rapporteur est efficacement éteinte lorsque la sonde est libre. Lors de l'hybridation de la sonde avec une cible complémentaire ou lors d'un clivage lorsqu'il est lié à une cible, le colorant rapporteur n'est plus éteint, ce qui produit une quantité de fluorescence détectable. La seconde amorce à fusion la plus basse peut être annelée et étendue de façon à produire un acide nucléique double brin. Des amplifications peuvent être surveillées en temps réel, notamment pour chaque cycle ou au niveau du point d'extrémité . Le protocole de formation de cycle thermique asynchrone de réaction en chaîne de la polymérase (PCR) peut produire une prépondérance de l'amplicon PCR sous une forme simple brin par répétition au niveau de l'extrémité du protocole permettant d'anneler et d'étendre l'amorce à fusion la plus élevée.
Patent EP-1315527-A2 (EP)
Inventor: BURTON SCOTT A
IPC: B32B7/02
Filed: 2001-08-28
Abstract: A multi-layer wound dressing comprising at least two absorbent layers, and materials for forming absorbent layers are provided. The absorbent layers have different absorbencies, with the layer closest to the wound having a lower absorbency than the layer furthest from the wound. The wound dressing typically contains additional non-absorbing layers, such as a backing film and wound-facing film. The dressing provides absorbency of wound exudates while preventing the absorbent material from entering the wound. In specific implementations the dressing is substantially transparent prior to application to a wound, as well as after application to the wound when body fluids have been absorbed.
Patent EP-1319066-A2 (EP)
Inventor: LI JIAYIN
IPC: C12N1/15
Filed: 2001-09-14
Abstract: The present invention provides amino acid sequences of peptides that are encoded by genes with the human genome, the kinase peptides of the the present invention. The present invetion specifically provides isolated peptide and nucleic acid molecules, methods of identifying orthologs and paralogs of the kinase peptides, and methods of identifying modulators of the kinase peptides.
Patent EP-1311959-A2 (EP)
Inventor: ANDERSON ALMA
IPC: G06F13/40
Filed: 2001-08-09
Abstract: A repeater employs multiple threshold detectors to distinguish between signals from external devices and signals generated within the repeater. Signals that are sent from the repeater are configured to be between two threshold levels, so that a detector at one threshold level will detect an active signal, but the detector at the other threshold level will not detect an active signal. When an external signal is received on one side (A) of the repeater, it is propagated to the other side (B) of the repeater, and at the same time, the other side (B) of the repeater is configured to only propagate external signals back to the first side (A). In this manner, the internally generated signal from one side (A) is not propagated back to the same side (A), and a latch-up is avoided. In like manner, when an external signal is received at the other side (B), the first side (A) of the repeater is configured to propagate only externally generated signals. If both sides of the repeater are externally driven, the active signal is propagated to both sides of the repeater, thereby emulating the response that would be provided by a wired bus without a repeater. The repeater is particularly well suited for an I2C bus architecture.
Patent EP-1324724-A2 (EP)
Inventor: BOYD LAWRENCE M
IPC: A61F2/46
Filed: 2001-09-18
Abstract: This invention relates to arthodesis for stabilizing the spine. More specifically, the present invention is directed to an intervertebral spacer formed of a bone material and to methods of treating patients having spinal deformities. The invention provides a spinal implant assembly comprising bone-derived components. The bone-derived components can be formed into modular units that can be assembled to provide a wide variety of implant configurations. In addition, the bone-derived components can form scaffold that can withstand the shear and impact forces necessary to insert the assembled implant into a disc space between adjacent vertebrae. In preferred forms the implants define an open spacer that serves as a depot for receipt of an osteoconductive material. The ostoegenic material is preferably a moldable filler that can form a molded reinforced implant.
Patent EP-1334190-A2 (EP)
Inventor: DELEERSNIJDER WILLY
IPC: G01N33/15
Filed: 2001-09-28
Abstract: The present invention relates to the IGS43 G-protein coupled receptor family, and to polynucleotides encoding said IGS43 proteins. The invention also relates to inhibiting or activating the action of such polynucleotides and polypeptides, to a vector containing said polynucleotides, a host cell containing such vector and non-human transgenic animals where the IGS43-gene is either overexpressed, misexpressed, underexpressed or suppressed (knock-out animals). The invention further relates to a method for screening compounds capable to act as an agonist or an antagonist of said G-protein coupled receptor family IGS43 and the use of IGS43 polypeptides and polynucleotides and agonists or antagonists to the IGS43 receptor family in the treatment of a broad range of disorders and diagnostic assays for such conditions. The invention in particular relates to a method for screening compounds capable to act as an agonist or an antagonist of said G-protein coupled receptor family IGS43 and the use of IGS43 polypeptides and polynucleotides and agonists or antagonists to the IGS43 receptor family in the treatment of dysfunctions, disorders, or diseases related to uterus, kidney, lung, trachea, colon, small intestine, stomach, mammary gland, prostate, testis, central nervous system, cerebellum, and spinal cord, and diagnostic assays for such conditions.
Patent EP-1327141-A2 (EP)
Inventor: STRAND DAVID
IPC: G16H20/17
Filed: 2001-10-05
Abstract: A fluid separation conduit cartridge comprising a fluid separation conduit is disclosed. In certain embodiments the fluid separation conduit is potted to provide operation at increased pressures. In other embodiments, the fluid separation conduit cartridge has one or more memory units. The memory units are operative to store data such as, for example, cartridge usage and test results.
Patent EP-1295512-A2 (EP)
Inventor: FOURIE LOUIS JOHANNES
IPC: F27B3/20
Filed: 2001-06-20
Abstract: An induction-heated furnace having a shell with at least a portion lined with refractory material having walls and a floor. At least one induction heater is mounted to the floor of the furnace refractory material that communicates with the interior of the furnace through a throat. The throat length is substantially longer than the throat length of the induction heater to aid the distribution of molten metal in the furnace.
Patent EP-1339858-A2 (EP)
Inventor: THOMPSON JOHN E
IPC: C12N15/82
Filed: 2001-11-29
Abstract: Regulation of expression of programmed cell death, including senescence, in plants is achieved by integration of a gene or gene fragment encoding senescence-induced eIF-5A or both into the plant genome in antisense orientation. Plant genes encoding senescence-induced deoxyhpusine synthase and senescence-induced elF-5A are identified and the nucleotide sequences of each, aon and in combination are used to modify senescence in transgenic plants
Patent EP-1379650-A2 (EP)
Inventor: FITZPATRICK JUDITH
IPC: A61K48/00
Filed: 2001-10-25
Abstract: The invention is directed to preferred repeat sequences of Neural Thread Protein (NTP), peptides, mimetics, antibodies, and nucleic acids of the preferred sequences, and diagnostic and therapeutic methods of using such preferred NTP sequences.
Patent EP-1381691-A2 (EP)
Inventor: DANENBERG KATHLEEN D
IPC: C12P19/34
Filed: 2001-11-09
Abstract: La présente invention concerne des méthodes de pronostics utilisées à des fins médicales, en particulier pour une chimiothérapie en cas de cancer. Le mode de réalisation décrit dans cette invention consiste à évaluer les niveaux d'expression de TS et/ou de ERCC1 dans des tissus incorporés fixés ou fixés puis imprégnés à la paraffine, et à établir un pronostic quant à la résistance probable de la tumeur d'un patient au traitement par des thérapies à base de 5-FU et d'oxaliplatine, par évaluation de la quantité d'ARNm TS et/ou ERCC1 dans les cellules tumorales d'un patient, puis par comparaison de celle-ci avec un niveau d'expression seuil prédéterminé pour ces gènes. Plus particulièrement, la présente invention concerne des paires d'amorces oligonucléotidiques ERCC1 et TS et des procédés consistant à les utiliser pour détecter les niveaux d'ARNm ERCC1 et TS, respectivement.
Patent EP-1246148-A2 (EP)
Inventor: WUESTEFELD MARTIN
IPC: G08B13/184
Filed: 2002-02-05
Abstract: A reflector (1) fits on the side of a protected area (5) opposite to an imaging lens (4) assigned to a light receiver (3) with localized resolution. A source of light (6) fits outside the protected area and/or on the side of the protected area opposite to the reflector. A memory stores an image captured by the light receiver if the protected area is free of an object. A comparing device compares an image captured at the moment with an image stored in memory.
Patent EP-1256794-A2 (EP)
Inventor: SHIMIZU HITOSHI
IPC: G01N21/64
Filed: 2002-05-08
Abstract: A biochemical analysis data producing method includes the steps
of selectively storing one of radiation energy and light energy in a
plurality of stimulable phosphor layer regions two-dimensionally formed
in a support of a stimulable phosphor sheet and spaced apart from each
other, moving the stimulable phosphor sheet and a stimulating ray
relative to each other in a main scanning direction and a sub-scanning
direction, sequentially irradiating the plurality of stimulable phosphor
layer regions so that energy of the stimulating ray projected onto the
plurality of stimulable phosphor layer regions per unit area is higher than
that projected on regions other than the plurality of stimulable phosphor
layer regions, thereby exciting stimulable phosphor contained in the
plurality of stimulable phosphor layer regions, and photoelectrically
detecting stimulated emission released from the stimulable phosphor
layer to produce biochemical analysis data. According to this method, it is
possible to effectively prevent the stimulating ray from entering a
neighboring stimulable phosphor layer region to be next stimulated as the
stimulating ray is scanned and thus prevent stimulable phosphor
contained in the neighboring stimulable phosphor layer region from being
excited to release radiation energy or light energy stored therein, and,
therefore, biochemical analysis data having an excellent quantitative
characteristic can be produced in a desired manner.
Patent EP-1279576-A2 (EP)
Inventor: SACHS EKKEHARD
IPC: H01H13/56
Filed: 2002-07-24
Abstract: The ignition lock system includes a carrier element (17) with a slot (104) for the key (102), which can move linearly like a pushrod. The movement setting (s3) for the carrier element is in the form of a locking setting, effected by the interaction of a heart-shaped cam (108) in which an elastically loaded locking pin (24) can engage.
Patent EP-1256321-A2 (EP)
Inventor: BAYS F BARRY
IPC: A61M1/00
Filed: 1997-09-24
Abstract: A powered handpiece for driving a surgical blade to cut anatomical tissue includes
a reusable handpiece body having a distal end for being coupled with a surgical blade, a
drive shaft in the handpiece body for rotatably driving the surgical blade, a motor assembly
for being installed in the handpiece body to rotatably drive the drive shaft and a suction
channel in the handpiece body including a portion extending through the drive shaft
parallel to a longitudinal axis of the motor assembly for evacuating anatomical tissue cut
by the blade from the handpiece body for external collection. The surgical blade is for use
with the powered handpiece and carries a sealing arrangement facilitating irrigation and
suction. The handpiece body is capable of being sterilized to medical standards prior to
each use. The motor assembly, which is non-sterile, is removable from the handpiece
body prior to sterilization of the handpiece body and is reinstallable in the handpiece body
subsequent to sterilization of the handpiece body without contaminating the sterilized
handpiece body. An installation device includes a reusable funnel for being disposed over
the handpiece body and through which the motor assembly is inserted for installation in
the handpiece body. An electric cord assembly for being coupled between the handpiece
and a power console includes a plug for being plugged into the motor assembly after the
motor assembly has been installed in the handpiece body and a locking ring on the plug
for selectively, releasably, lockingly engaging the handpiece body to secure the motor
assembly in the handpiece body.
Patent EP-1296315-A2 (EP)
Inventor: NODA EIJI
IPC: G11B7/243
Filed: 2002-09-25
Abstract: A phase change optical information recording medium
including: a substrate; and a recording layer which is located
overlying the substrate and in which marks are to be formed to
store information, wherein the substrate includes plural
sessions including a first session in which pits are formed and
which includes a RAM region including a groove and a wobble
signal, and a program memory area in which pits are formed and
which includes position information of the first session and
does not include disc ID information of the phase change optical
information recording medium.
Patent EP-1318700-A2 (EP)
Inventor: MOSER HELMUT DIPL-RER POL
IPC: H05B33/02
Filed: 2002-12-10
Abstract: The electrically conducting elastomer cord (1) has a metal wire at the core (2) and is covered by a thin reflecting and isolating layer (3). This is then coated with an electroluminescent layer (4). A final transparent electrically conducting layer (5) completes the construction.
Patent EP-1284140-A2 (EP)
Inventor: NORBECK DANIEL W
IPC: C07D277/28
Filed: 1996-06-28
Abstract: There is described a combination of ritonavir or a pharmaceutically acceptable salt
thereof in combination with another HIV protease inhibitor, formulated as a single or
separate composition, for
use in the inhibition or treatment of an HIV infection or AIDS in a human host.
Patent EP-1240869-A2 (EP)
Inventor: JORDFALD DAG
IPC: G01B7/30
Filed: 2002-03-13
Abstract: A system and method for measuring a position of an imaging element (436)
located within a scan head (120) of an imaging probe, such as
transesophageal ultrasound probe (100), is provided. The imaging probe may
be used in a medical imaging system and/or a three-dimensional imaging
system. The probe includes an articulating portion (115) having a scan head
(120). The scan head (120) includes an imaging element (436), such as a
transducer, and a position sensor positioned within the scan head (120).
Preferably, the position sensor is connected to the imaging element (436) via
an axle (510). Therefore, the rotation of the position sensor is synchronized
to the rotation of the imaging element (436). The location of the position
sensor within the imaging element (436) provides accurate measurement of
the position of the imaging element (436). The position sensor preferably
includes a code disk having apertures (530) and a system of light emitters
(524, 528) and detectors (514, 518). As the code disk rotates in
synchronization with the imaging element (436), the pattern of detection of
light through the apertures (530) measures the position of the imaging
element (436). Various alternative position sensors, such as potentiometers,
may be utilized within the scan head (120) of the probe. The probe also
includes a control handle (130) having imaging and articulation controls.
Patent EP-1326277-A2 (EP)
Inventor: HIKOSAKA YUKINOBU
IPC: H01L21/8238
Filed: 2002-08-14
Abstract: A semiconductor device having a conductive plug
(10a, 10d, 12a, 12b) for connecting a capacitor (Q 1 , Q 2 )
and a conductive pattern (13, 15), comprises first and
second impurity diffusion regions (5a, 5b, 5d, 5e)
formed in a semiconductor substrate (1), a first
insulating film (8) formed over the semiconductor
substrate (1), a first hole formed in the first
insulating film (8) on the first impurity diffusion
region (5a), a first conductive plug (10a) formed in
the first hole and made of a metal film, a second hole
formed in the first insulating film (8) on the second
impurity diffusion region (5b), a second conductive
plug (10d) formed in the second hole and made of
conductive material that is more difficult to oxidise
than the metal film, and a capacitor (Q 1 ) that consists
of a lower electrode (13a) connected to an upper
surface of the fourth conductive plug (12a), a
dielectric film (14a), and an upper electrode (15a).
Patent EP-1308739-A2 (EP)
Inventor: MINAMIURA KEIICHI
IPC: G01R31/36
Filed: 2002-11-04
Abstract: A battery pack system (10) is composed of a plurality of
battery pack blocks (1a, 1b, 1c, 1d), each of which is
constituted by connecting a plurality of cells in series, that
are connected with one another by a combination of serial
connection and parallel connection. The battery pack blocks
are each provided with a current sensor (4a, 4b, 4c, 4d) for
detecting current values. Detection results are inputted to a
control section (5), which processes the detected current
values using an algorithm constructed in accordance with the
connection status of the battery pack blocks. Thereby, an
abnormality of the battery pack block is detected, and an
abnormal battery pack block is identified.